NSE: JYOTHYLAB | BSE: 532926

Expensive Underperformer

Download real time

336.00 -2.75 (-0.81%)

43.61% Fall from 52W High

127.0K NSE+BSE Volume

NSE 22 May, 2025 10:33 AM (IST)

12,338.4

Market Cap

Below industry Median

0.5

Beta 1Year

Very Low volatility

Jyothy Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JYOTHYLAB, BSE:532926 Jyothy Labs Ltd.

Jyothy Labs Ltd.

28 Jun 2018

336.00

-0.81%

Jyothy Laboratories

Buy: Jyothy Labs Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Jyothy Laboratories (JLL) made an announcement of bonus shares on May 16, 2018. The ratio was one bonus share for every existing equity share i.e. 1:1. The record date for the same is June 30, 2018 while the ex-date for the same is today i.e. June 28, 2018. Consequently, Jyothy Laboratories' share price, as per yesterday's closing price, has adjusted to | 222/share from | 444/share. Hence, now our target price also stands revised to...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

13 Jun 2018

336.00

-0.81%

Jyothy Laboratories Ltd: Positive momentum continued on the ...

Hold: Jyothy Labs Ltd.

Karvy

Positive momentum continued on the back of Double Digit Growth in Volumes: Jyothy Laboratories Ltd (JLL) has reported healthy set of volume numbers i.e. 11.4% growth in Q4FY18 and we expect that the management will be able to continue the momentum in volumes. Revenue from operations of the company improved to Rs. 5168 Mn in Q4FY18 from Rs. 4661 Mn in Q4FY17 registering 10.9% growth YoY

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

21 May 2018, 12:00AM

336.00

-0.81%

Jyothy Laboratories Ltd. - Result Update - 21 May 2018

Hold: Jyothy Labs Ltd.

Way2Wealth

Reported standalone revenues stood at `505.4 crs in Q4FY18 and at `1699crs for FY18, registering a growth of 16.7% & 4.1% respectively. EBIDTA grew by 44.4% Y-O-Y to `90.6 crs in the quarter. EBIDTA margins stood at 17.9% vs.14.5% in the same period last year. EBIDTA for FY18 stood at `277.5 crs...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

17 May 2018

336.00

-0.81%

Jyothy Laboratories

Buy: Jyothy Labs Ltd.

ICICI Securities Limited

Operating margin improved 344 bps to 17.9% mainly on the back of 720 bps surge in gross margins. A&P; spend increase of 90% to | 53.1 crore is part of the company's strategy to increase advertisements in power brands specifically in Henko & Margo JLL had adjusted tax losses of | 65.6 crore in Q4FY17 on account of approval of merger of Jyothy Consumer Products Marketing with JLL. This led to tax reversal. Hence, reported PAT was lower 45.1% YoY to | 60.4 crore. JLL reported other income of | 22.1...

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

16 May 2018

336.00

-0.81%

Jyothy Laboratories: Positive rural outlook; raw material inflation - a key monitorable

Neutral: Jyothy Labs Ltd.

Motilal Oswal

Net sales rose 15.8% YoY to INR5.16b (est. of INR5.11b) in 4QFY18.EBITDA grew 45.8% YoY to INR884m (est. of INR791m). Adj. PAT after non-controlling interest fell 55.2% YoY to INR487m (est. of INR543m). Fabric care, Dish washing and Personal care grew 13.6%, 21.3% and 54.0%, respectively, while Household insecticides fell 10% YoY on a like-to-like basis adjusted for GST.

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

11 Apr 2018

336.00

-0.81%

The Corner Office: Brightening the portfolio..

Strategy Note: Jyothy Labs Ltd.

Motilal Oswal

This product fits well into JYL's niche and innovative product portfolio. It was launched initially in Kerala, with the potential to reach a customer base of over 30m people. JYL initially targets to make Ujala Crisp and Shine an INR1b sales product in south India, and then take the brand to other states - but one state at a time. It targets a turnover of INR2.5b from this brand over 4-5 years. After regaining the lost market share in the household insecticides business, Maxo is expected to do better in the coming years, led by government initiatives (such as Swachh Bharat) and lower competitive intensity. Mortein (Reckitt) has not been doing well in the market, as is the case globally. All out (SC Johnson) has also lost focus on liquids. Both these brands are losing share to Good Knight (GCPL) and Maxo (JYL). GoodKnight is very strong in south India and Maxo in east India.

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

22 Feb 2018, 12:00AM

336.00

-0.81%

Jyothy Laboratories Ltd: Double Digit Growth in Volumes on t... (Feb 22, 2018)

Hold: Jyothy Labs Ltd.

Karvy

Double Digit Growth in Volumes on the Back of Personal Care, Dishwashing and Fabric Care Segments: Jyothy Laboratories Ltd (JLL) has reported healthy set of volume numbers i.e. 11.5% in Q3FY18 and we expect that the management will be able to maintain 8-10% volume growth going forward. Revenue from Operations of the company improved to Rs. 4312 Mn during the quarter from Rs. 3983 Mn during Q3FY17 registering 8.3% growth YoY.

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

23 Jan 2018

336.00

-0.81%

Result Update:Jyothy Lab.

Hold: Jyothy Labs Ltd.

Axis Direct

Q3FY18 in line: Consolidated net sales, EBITDA, and adj. PAT grew 16% (adjusted for GST accounting), 37% and 61% (vs. consensus estimates of 15%, 32% and 100%). Volume grew 11.5% aided by weak base and gradual recovery in supply chain.

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

19 Jan 2018

336.00

-0.81%

Jyothy Laboratories

Buy: Jyothy Labs Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Jyothy Labs (JLL) posted healthy 8.3% revenue growth (GST comparable growth: 15.9%) to | 417.5 crore led by 11.5% volume growth. The strong volume growth was on the back of 3.6% volume dip in base quarter due to demonetisation impact. Also, rural demand scenario improved due to normal monsoon in 2017 Power brands Ujala, Exo, Henko, Margo and Pril witnessed strong growth of 17.3%, 19.1%, 23% and 43.4%, respectively. However,...

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

19 Jan 2018

336.00

-0.81%

Jyothy Laboratories Ltd. - Result Update - 19 January 2018

Hold: Jyothy Labs Ltd.

Way2Wealth

1. The company reported a GST comparable topline growth of 15.9% to `431 crs. The growth was driven by the dishwashing and personal care categories. Volume grew by 11.5% YoY. Power brands GST comparable growth was at 17.5%. 2. Operating profit in Q3 grew by 36.8% to `69.3crs. with margins expanding from13.2%...

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Is Jyothy Labs Ltd. worth buying?

280 Votes:

Buy 80.71%

Sell 11.43%

Hold 7.86%

RESEARCH REPORTS

Neutral SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf